Filing metadata

Accession number
0001140361-21-023007
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jun 30, 2021
Reporting period
Jun 28, 2021
Description
Insider transaction

Explore SEC Filings Hub